Stroke - Pipeline Review, H2 2018

Publisher Name :
Date: 11-Sep-2018
No. of pages: 544
Inquire Before Buying

Stroke - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2018, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They may complain of a sudden headache. They may have sudden numbness in their face or limbs, particularly down one side of their body. They may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Stroke - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 10, 26, 23, 2, 104, 15 and 1 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 31 and 4 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Stroke (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Stroke (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Stroke (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Stroke (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Stroke (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Stroke (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Stroke (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Stroke - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 7
Stroke - Overview 8
Stroke - Therapeutics Development 9
Stroke - Therapeutics Assessment 34
Stroke - Companies Involved in Therapeutics Development 50
Stroke - Drug Profiles 91
Stroke - Dormant Projects 495
Stroke - Discontinued Products 508
Stroke - Product Development Milestones 511
Appendix 522

List of Tables
Number of Products under Development for Stroke, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Stroke - Pipeline by Acorda Therapeutics Inc, H2 2018
Stroke - Pipeline by Acticor Biotech SAS, H2 2018
Stroke - Pipeline by Addex Therapeutics Ltd, H2 2018
Stroke - Pipeline by Affibody AB, H2 2018
Stroke - Pipeline by Amarantus Bioscience Holdings Inc, H2 2018
Stroke - Pipeline by Anavex Life Sciences Corp, H2 2018
Stroke - Pipeline by Antoxis Ltd, H2 2018
Stroke - Pipeline by Apellis Pharmaceuticals Inc, H2 2018
Stroke - Pipeline by AptaTargets SL, H2 2018
Stroke - Pipeline by ArmaGen Inc, H2 2018
Stroke - Pipeline by Artelo Biosciences Inc, H2 2018
Stroke - Pipeline by ArunA Biomedical Inc, H2 2018
Stroke - Pipeline by AstraZeneca Plc, H2 2018
Stroke - Pipeline by Athersys Inc, H2 2018
Stroke - Pipeline by BioAxone BioSciences Inc, H2 2018
Stroke - Pipeline by Biogen Inc, H2 2018
Stroke - Pipeline by BioTime Inc, H2 2018
Stroke - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Stroke - Pipeline by Cardax Inc, H2 2018
Stroke - Pipeline by Celltrion Inc, H2 2018
Stroke - Pipeline by CHA Bio & Diostech Co Ltd, H2 2018
Stroke - Pipeline by CohBar Inc, H2 2018
Stroke - Pipeline by Daiichi Sankyo Co Ltd, H2 2018
Stroke - Pipeline by DiaMedica Therapeutics Inc, H2 2018
Stroke - Pipeline by Diffusion Pharmaceuticals Inc, H2 2018
Stroke - Pipeline by Epigen Biosciences Inc, H2 2018
Stroke - Pipeline by Evgen Pharma Plc, H2 2018
Stroke - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Stroke - Pipeline by Fina Biotech SL, H2 2018
Stroke - Pipeline by Freeox Biotech SL, H2 2018
Stroke - Pipeline by GC Pharma, H2 2018
Stroke - Pipeline by Genervon Biopharmaceuticals LLC, H2 2018
Stroke - Pipeline by Glialogix Inc, H2 2018
Stroke - Pipeline by Glucox Biotech AB, H2 2018
Stroke - Pipeline by Immunwork Inc, H2 2018
Stroke - Pipeline by Instituto Biomar SA, H2 2018
Stroke - Pipeline by International Stem Cell Corp, H2 2018
Stroke - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2018
Stroke - Pipeline by JT Pharmaceuticals Inc, H2 2018
Stroke - Pipeline by Les Laboratoires Servier SAS, H2 2018
Stroke - Pipeline by Living Cell Technologies Ltd, H2 2018
Stroke - Pipeline by Lixte Biotechnology Holdings Inc, H2 2018
Stroke - Pipeline by Lumosa Therapeutics Co Ltd, H2 2018
Stroke - Pipeline by M et P Pharma AG, H2 2018
Stroke - Pipeline by Mapreg SAS, H2 2018
Stroke - Pipeline by Meridigen Biotech Co Ltd, H2 2018
Stroke - Pipeline by Neuralstem Inc, H2 2018
Stroke - Pipeline by Neuren Pharmaceuticals Ltd, H2 2018
Stroke - Pipeline by Neurofx Inc, H2 2018
Stroke - Pipeline by NeuroNascent Inc, H2 2018
Stroke - Pipeline by NeurOp Inc, H2 2018
Stroke - Pipeline by New World Laboratories Inc, H2 2018
Stroke - Pipeline by Nipro Corp, H2 2018
Stroke - Pipeline by NoNO Inc, H2 2018

List of Figures
Number of Products under Development for Stroke, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018
  • Global Myocardial Infarction Drugs Market Data Survey Report 2013-2025
    Published: 20-Mar-2019        Price: US 1500 Onwards        Pages: 67
    Summary The global Myocardial Infarction Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on comp......
  • Global Rosuvastatin Calcium Market Data Survey Report 2013-2025
    Published: 20-Mar-2019        Price: US 1500 Onwards        Pages: 61
    Summary Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal ......
  • Global Rosuvastatin Market Insights, Forecast to 2025
    Published: 20-Mar-2019        Price: US 3900 Onwards        Pages: 113
    Global Rosuvastatin market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Rosuvastatin. This report researches the worldwide Rosuvastatin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions. ......
  • Ischemia Reperfusion Injury - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 163
    Ischemia Reperfusion Injury - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury - Pipeline Review, H1 2019, provides an overview of the Ischemia Reperfusion Injury (Cardiovascular) pipeline landscape. Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nut......
  • Myocarditis - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 37
    Myocarditis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H1 2019, provides an overview of the Myocarditis (Cardiovascular) pipeline landscape. Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reach the heart. Symptoms include chest pain, rapid or abn......
  • Restenosis - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H1 2019, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family history ......
  • Pulmonary Arterial Hypertension - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 304
    Pulmonary Arterial Hypertension - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H1 2019, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood t......
  • Myocardial Infarction - Pipeline Review, H1 2019
    Published: 18-Mar-2019        Price: US 2000 Onwards        Pages: 294
    Myocardial Infarction - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Infarction - Pipeline Review, H1 2019, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain,......
  • Global Atorvastatin Calcium Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Mar-2019        Price: US 3480 Onwards        Pages: 138
    Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8. Scope of the Report: Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It cont......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs